Please Wait.....
Report
Research on South America Granulocyte-Colony Stimulating Factor Industry Strategy Analysis (Impact of Covid-19)
Market Report I 2022-11-08 I 115 Pages I Arsta Research
As the South American economy recovers in 2021 and the supply of the industrial chain improves, the Granulocyte-Colony Stimulating Factor market will undergo major changes. According to the latest research, the market size of the Granulocyte-Colony Stimulating Factor industry in 2022 will increase by USD million compared to 2021, with a growth rate of %.
The South American Granulocyte-Colony Stimulating Factor industry report provides top-notch qualitative and quantitative information including: Market size (2018-2022 value and 2023 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the South American Granulocyte-Colony Stimulating Factor market during the next few years. Market research reports are an essential resource for businesses seeking to maximize the market potential. The report provides extensive data, insights, and analysis to enable businesses to make informed decisions, drive growth, and achieve success.
Highlights-Regions
The Granulocyte-Colony Stimulating Factor market can be split based on product types, major applications, and important regions as follows:
Brazil
Argentina
Chile
Colombia
Peru
Player list
Stada Arzneimittel AG
Biocad
Pfizer Inc
Dong-A Socio Group
Teva Pharmaceutical Industries Ltd
Mylan
Amgen Inc
Intas Pharmaceuticals Ltd
Merck KGaA
Dr. Reddy's Laboratories
Novartis
Biocon
Celltrion Inc
Types list
Capsule
Tablet
Others
Application list
Oncology
Blood Disorders
Growth Hormone Deficiencies
Chronic and Autoimmune Disorders
Other Applications
Table of Content
1 Granulocyte-Colony Stimulating Factor Market Overview
1.1 Product Overview and Scope of Interactive White board
1.2 Granulocyte-Colony Stimulating Factor Segment by Type
1.2.1 South America Granulocyte-Colony Stimulating Factor Sales Growth Rate Comparison by Type (2023 VS 2029)
1.3 Market Analysis by Application
1.3.1 Granulocyte-Colony Stimulating Factor Sales Comparison by Application (2023 VS 2029)
1.4 South America Market Growth Prospects
1.4.1 South America Granulocyte-Colony Stimulating Factor Revenue Estimates and Forecasts (2018-2029)
1.4.2 South America Granulocyte-Colony Stimulating Factor Sales Estimates and Forecasts (2018-2029)
1.4.3 South America Granulocyte-Colony Stimulating Factor Market Size Estimates and Forecasts by Region: 2018 VS 2023 VS 2029
1.5 Coronavirus Disease (COVID-19) Impact on Global
1.6 COVID 19 Impact on Granulocyte-Colony Stimulating Factor Market
1.6.1. COVID-19 Landscape: Granulocyte-Colony Stimulating Factor Industry Impact
1.6.2. COVID 19 - Impact Assessment for the Industry
1.6.3. COVID 19 Impact: Global Major Government Policy
1.6.4. Market Trends and Opportunities in the COVID-19 Landscape
2 Market Competition by Manufacturers
2.1 South America Granulocyte-Colony Stimulating Factor Sales and Market Share by Manufacturer
2.2 South America Granulocyte-Colony Stimulating Factor Revenue and Market Share by Manufacturer
2.3 South America Granulocyte-Colony Stimulating Factor Average Price by Manufacturers
2.4 Manufacturers Granulocyte-Colony Stimulating Factor Production Sites, Area Served, Product Types
2.5 Granulocyte-Colony Stimulating Factor Market Competitive Situation and Trends
2.5.1 Granulocyte-Colony Stimulating Factor Market Concentration Rate
2.5.2 South America Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Mergers & Acquisitions, Expansion
3 Granulocyte-Colony Stimulating Factor Manufacturing Cost Analysis
3.1 Granulocyte-Colony Stimulating Factor Key Raw Materials Analysis
3.1.1 Key Raw Materials
3.1.2 Key Suppliers of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
3.3 Manufacturing Process Analysis
3.4 Granulocyte-Colony Stimulating Factor Chain Analysis
4 Marketing Channel, Distributors and Customers
4.1 Marketing Channel
4.2 Granulocyte-Colony Stimulating Factor Distributors List
4.3 Granulocyte-Colony Stimulating Factor Customers
5 Granulocyte-Colony Stimulating Factor Retrospective Market Scenario by Region
5.1 South America Granulocyte-Colony Stimulating Factor Retrospective Market Scenario in Consumption 2018-2023
5.2 South America Granulocyte-Colony Stimulating Factor Consumption
5.2.1 South America Granulocyte-Colony Stimulating Factor Consumption by Country (2018-2023)
5.2.2 South America Granulocyte-Colony Stimulating Factor Revenue by Country (2018-2023)
5.2.3 Brazil Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
5.2.4 Argentina Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
5.2.5 Chile Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
5.2.6 Colombia Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
5.2.7 Peru Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
6 South America Granulocyte-Colony Stimulating Factor Sales, Revenue, Price Trend by Type
6.1 South America Granulocyte-Colony Stimulating Factor Sales and Market Share by Type (2018-2023)
6.2 South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Type (2018-2023)
6.3 South America Granulocyte-Colony Stimulating Factor Price by Type (2018-2023)
7 South America Granulocyte-Colony Stimulating Factor Consumption Analysis by Application
7.1 South America Granulocyte-Colony Stimulating Factor Consumption Market Share by Application (2018-2023)
7.2 South America Granulocyte-Colony Stimulating Factor Consumption Growth Rate by Application (2018-2023)
8 Manufacturers Profiles
8.1 Stada Arzneimittel AG
8.1.1 Business Overview
8.1.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.1.3 Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.2 Biocad
8.2.1 Business Overview
8.2.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.2.3 Biocad Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.3 Pfizer Inc
8.3.1 Business Overview
8.3.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.3.3 Pfizer Inc Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.4 Dong-A Socio Group
8.4.1 Business Overview
8.4.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.4.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.5 Teva Pharmaceutical Industries Ltd
8.5.1 Business Overview
8.5.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.5.3 Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.6 Mylan
8.6.1 Business Overview
8.6.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.6.3 Mylan Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.7 Amgen Inc
8.7.1 Business Overview
8.7.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.7.3 Amgen Inc Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.8 Intas Pharmaceuticals Ltd
8.8.1 Business Overview
8.8.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.8.3 Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.9 Merck KGaA
8.9.1 Business Overview
8.9.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.9.3 Merck KGaA Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.10 Dr. Reddy's Laboratories
8.10.1 Business Overview
8.10.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.10.3 Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.11 Novartis
8.11.1 Business Overview
8.11.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.11.3 Novartis Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.12 Biocon
8.12.1 Business Overview
8.12.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.12.3 Biocon Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
8.13 Celltrion Inc
8.13.1 Business Overview
8.13.2 Granulocyte-Colony Stimulating Factor Product Introduction
8.13.3 Celltrion Inc Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin
9 Granulocyte-Colony Stimulating Factor Market Dynamics
9.1 Granulocyte-Colony Stimulating Factor Industry Trends
9.2 Granulocyte-Colony Stimulating Factor Growth Drivers
9.3 Granulocyte-Colony Stimulating Factor Market Challenges
9.4 Granulocyte-Colony Stimulating Factor Market Restraints
10 Forecast by Type and By Application (2023-2029)
10.1 South America Sales, Revenue and Price Forecast by Type (2023-2029)
10.1.1 South America Forecasted Sales of Granulocyte-Colony Stimulating Factor by Type (2023-2029)
10.1.2 South America Forecasted Revenue of Granulocyte-Colony Stimulating Factor by Type (2023-2029)
10.1.3 South America Forecasted Price of Granulocyte-Colony Stimulating Factor by Type (2023-2029)
10.2 South America Sales, Revenue and Price Forecast by Application (2023-2029)
10.2.1 South America Forecasted Sales of Granulocyte-Colony Stimulating Factor by Application (2023-2029)
10.2.2 South America Forecasted Revenue of Granulocyte-Colony Stimulating Factor by Application (2023-2029)
10.2.3 South America Forecasted Price of Granulocyte-Colony Stimulating Factor by Application (2023-2029)
10.3 South America Granulocyte-Colony Stimulating Factor Market Estimates and Projections by Region
10.3.1 South America Forecasted Sales of Granulocyte-Colony Stimulating Factor (2023-2029)
10.3.2 South America Forecasted Revenue of Granulocyte-Colony Stimulating Factor (2023-2029)
Research Findings and Conclusion
Methodology and Data Source
A Methodology
Research Process
Market Size Estimation
Market Breakdown and Data Triangulation
B Data Source
Legal Disclaimer
List of Tables and Figures
Figure Granulocyte-Colony Stimulating Factor Picture
Table South America Granulocyte-Colony Stimulating Factor Market Size by Type (Volume) & (2023 VS 2029)
Table South America Granulocyte-Colony Stimulating Factor Consumption Comparison by Application: 2023 VS 2029
Figure South America Granulocyte-Colony Stimulating Factor Revenue ($) and Growth Rate (2018-2029)
Figure South America Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2018-2029)
Table Granulocyte-Colony Stimulating Factor Market Size Comparison by Region: 2018 VS 2023 VS 2029
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table COVID-19 Landscape: Granulocyte-Colony Stimulating Factor Industry Impact
Table COVID 19 - Impact Assessment for the Industry
Table COVID 19 Impact: Global Major Government Policy
Table Market Trends and Opportunities in the COVID-19 Landscape
Table South America Granulocyte-Colony Stimulating Factor Sales by Manufacturer (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Sales Market Share by Manufacturer (2018-2023)
Figure South America Granulocyte-Colony Stimulating Factor Sales Market Share by Manufacturer in 2023
Table South America Granulocyte-Colony Stimulating Factor Revenue ($) by Manufacturer (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Manufacturer (2018-2023)
Figure South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Manufacturer in 2023
Table South America Granulocyte-Colony Stimulating Factor Price by Manufacturer (2018-2023)
Table Manufacturers Granulocyte-Colony Stimulating Factor Production Sites, Area Served, Product Types
Table Granulocyte-Colony Stimulating Factor Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Proportion of Manufacturing Cost Structure
Table Granulocyte-Colony Stimulating Factor Chain Analysis
Figure Marketing Channel
Table Major Distributors of Granulocyte-Colony Stimulating Factor with Contact Information
Table Major Customers of Granulocyte-Colony Stimulating Factor with Contact Information
Figure South America Granulocyte-Colony Stimulating Factor Consumption 2018-2023
Table South America Granulocyte-Colony Stimulating Factor Consumption by Countries (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Consumption Market Share by Countries (2018-2023)
Figure South America Granulocyte-Colony Stimulating Factor Consumption Market Share by Countries in 2018
Figure South America Granulocyte-Colony Stimulating Factor Consumption Market Share by Countries in 2023
Table South America Granulocyte-Colony Stimulating Factor Revenue by Countries (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2018-2023)
Figure South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries in 2018
Figure South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries in 2023
Figure Brazil Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
Figure Brazil Granulocyte-Colony Stimulating Factor Revenue and Growth (2018-2023)
Figure Argentina Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
Figure Argentina Granulocyte-Colony Stimulating Factor Revenue and Growth (2018-2023)
Figure Chile Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
Figure Chile Granulocyte-Colony Stimulating Factor Revenue and Growth (2018-2023)
Figure Colombia Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
Figure Colombia Granulocyte-Colony Stimulating Factor Revenue and Growth (2018-2023)
Figure Peru Granulocyte-Colony Stimulating Factor Consumption and Growth (2018-2023)
Figure Peru Granulocyte-Colony Stimulating Factor Revenue and Growth (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Sales by Types (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Sales Market Share by Types (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Revenue by Types (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Types (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Price by Types (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Consumption by Application (2018-2023)
Table South America Granulocyte-Colony Stimulating Factor Consumption Share by Application (2018-2023)
Table Stada Arzneimittel AG Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Stada Arzneimittel AG Sales and Growth Rate
Figure Stada Arzneimittel AG Revenue ($) Market Share 2018-2023
Table Biocad Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Biocad Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Biocad Sales and Growth Rate
Figure Biocad Revenue ($) Market Share 2018-2023
Table Pfizer Inc Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Pfizer Inc Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Pfizer Inc Sales and Growth Rate
Figure Pfizer Inc Revenue ($) Market Share 2018-2023
Table Dong-A Socio Group Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Dong-A Socio Group Sales and Growth Rate
Figure Dong-A Socio Group Revenue ($) Market Share 2018-2023
Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Teva Pharmaceutical Industries Ltd Sales and Growth Rate
Figure Teva Pharmaceutical Industries Ltd Revenue ($) Market Share 2018-2023
Table Mylan Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Mylan Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Mylan Sales and Growth Rate
Figure Mylan Revenue ($) Market Share 2018-2023
Table Amgen Inc Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Amgen Inc Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Amgen Inc Sales and Growth Rate
Figure Amgen Inc Revenue ($) Market Share 2018-2023
Table Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Intas Pharmaceuticals Ltd Sales and Growth Rate
Figure Intas Pharmaceuticals Ltd Revenue ($) Market Share 2018-2023
Table Merck KGaA Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Merck KGaA Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Merck KGaA Sales and Growth Rate
Figure Merck KGaA Revenue ($) Market Share 2018-2023
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Dr. Reddy's Laboratories Sales and Growth Rate
Figure Dr. Reddy's Laboratories Revenue ($) Market Share 2018-2023
Table Novartis Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Novartis Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Novartis Sales and Growth Rate
Figure Novartis Revenue ($) Market Share 2018-2023
Table Biocon Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Biocon Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Biocon Sales and Growth Rate
Figure Biocon Revenue ($) Market Share 2018-2023
Table Celltrion Inc Basic Information, Manufacturing Base
Table Granulocyte-Colony Stimulating Factor Product Introduction, Application and Specification
Table Celltrion Inc Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Celltrion Inc Sales and Growth Rate
Figure Celltrion Inc Revenue ($) Market Share 2018-2023
Table South America Granulocyte-Colony Stimulating Factor Sales Forecast by Types (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Market Share Forecast by Types (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Revenue Forecast by Types (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Market Share Forecast by Types (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Price Forecast by Types (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Sales Forecast by Application (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Market Share Forecast by Application (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Revenue Forecast by Application (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Market Share Forecast by Application (2023-2029)
Table South America Granulocyte-Colony Stimulating Factor Price Forecast by Application (2023-2029)
Figure South America Forecasted Sales of Granulocyte-Colony Stimulating Factor (2023-2029)
Figure South America Forecasted Sales of Granulocyte-Colony Stimulating Factor (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security